New cream tested for stubborn hair loss condition
NCT ID NCT05416333
Summary
This small, early-stage study is testing whether a cream containing azelaic acid can help control Central Centrifugal Cicatricial Alopecia (CCCA), a type of scarring hair loss that mostly affects women. Researchers are comparing the cream against a placebo to see if it reduces inflammation and might help slow hair loss or promote regrowth. The study involves 18 women who have been diagnosed with CCCA and are on stable treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest University Health Scieces
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.